Search results
Results from the WOW.Com Content Network
The respiratory vaccines are priced lower than other vaccines, like Merck's HPV vaccine, Gardasil, which has a list price of $300 or more. (List price for Moderna's COVID vaccine: $110.) (List ...
COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region. As of July 2022, it is estimated that about 89.7% of the country's population has received a vaccine, and about 56% of the ...
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, [ 2 ] the Sinopharm COVID-19 vaccine, [ 3 ] or BIBP vaccine, [ 3 ][ 4 ][ 5 ] is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm 's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, [ 6 ] resulting ...
v. t. e. The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [ 1 ] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. [ 32 ] It contains a recombinant spike protein from the SARS-CoV-2 Omicron variant lineage JN.1.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
Shares of the vaccine maker tumbled 17.1% to $65.88 at midday. The company expects sales between $2.5 billion and $3.5 billion in 2025, below analysts' forecast of $3.74 billion, according to LSEG ...
The facility set a goal of supplying COVID‑19 vaccines to nearly 100 low-to-middle income countries that could not afford them. COVAX sought to fundraise US$6.8 billion to purchase and deliver vaccines to participating countries in proportion to their populations. [ 32 ]
t. e. Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. [7][8][9] In April 2022, the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine, being the first in the world to ...